Partner Content Partner Content How Will Spark’s Approval Impact the Gene Therapy Field? Gene Therapy for Rare Disorders Summit
Market Access Row over CF drug funding as NHS rejects Vertex offer Vertex 'astonished and dismayed' by NHS rejection
News Alexion to file successor to rare diseases drug Soliris New drug is in patient-friendly subcutaneous form
Events Partner Content International Neurology Conference Neurology-2018 welcomes you all to esteemed conference
Views & Analysis Four new rare disease treatments awaiting NICE review Following yesterday’s international Rare Disease Day, here is a snapshot of four new rare disease treatments currently under review by England’s cost-effectiveness watchdog.
News Study finds AZ's benralizumab a 'game-changer' in asthma Researchers in the UK say that AstraZeneca's benralizumab can have a dramatic impact if it was used to treat acute asthma attacks
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
